The injectable nanomedicines market is projected to grow from USD 20.4 billion in 2025 to USD 64.6 billion by 2035, at a CAGR of 12.2%. Liposomes will dominate with a 34.0% market share, while cancers will lead the application segment with a 32.0% share.